Bryan P. Schneider

Oncology

550 University Blvd
Indianapolis, IN 46202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 165 publications

Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.

Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: July 09, 2026

Retraction Note: Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.

Retraction Note: Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.

Journal: Nature communications

Published: July 07, 2026

Neurofilament Light Chain: A Potential Biomarker for Chemotherapy-Induced Peripheral Neuropathy in Adolescent Young Adults.

Neurofilament Light Chain: A Potential Biomarker for Chemotherapy-Induced Peripheral Neuropathy in Adolescent Young Adults.

Journal: Journal of adolescent and young adult oncology

Published: July 01, 2026

The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology.

The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology.

Journal: Research square

Published: June 12, 2026

The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.

The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.

Journal: Research square

Published: June 12, 2026

Amendment to Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer.

Amendment to Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer.

Journal: The Journal of clinical investigation

Published: May 01, 2026

Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer.

Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer.

Journal: JAMA network open

Published: April 10, 2026

From Prognosis to Action: Circulating Tumor DNA and the Next Phase of Risk Stratification in Triple-Negative Breast Cancer.

From Prognosis to Action: Circulating Tumor DNA and the Next Phase of Risk Stratification in Triple-Negative Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 18, 2026

Rare irAEs associated with immune checkpoint inhibitor therapy.

Rare irAEs associated with immune checkpoint inhibitor therapy.

Journal: Expert opinion on drug safety

Published: February 10, 2026

Retraction for Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer.

Retraction for Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer.

Journal: The Journal of clinical investigation

Published: January 16, 2026

Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171.

Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171.

Journal: Cancer

Published: January 12, 2026

NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.

NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 10, 2025

Showing 1-12 of 165

Last Updated: 09/26/2026